Is pharmacologically inefficient
Search terms included combinations of GLP-1 receptor agonist, semaglutide, liraglutide, tirzepatide, cutaneous side effects, dermatology, hidradenitis, psoriasis, bullous pemphigoid, facial aging, and plastic surgery. Of 260 articles initially identified, 155 were included on the basis of predefined eligibility criteria prioritizing randomized controlled trials, observational studies, systematic reviews, regulatory reports, and clinically relevant case series in adult populations
Healthcare Economics USA Today reportsthat Americans often spend more than $800 per month on GLP-1s for weight loss
Food and Drug Administration (FDA or the Agency), led by Commissioner Makary, intends to exercise its enforcement
Genetic variations in GLP-1 receptor function, GIPR sensitivity, and appetite-regulation pathways influence both efficacy and side effect tolerance